Editorial

Weight gain on dolutegravir: Association is not the same as causation

Gary Maartens, Phumla Sinxadi, W.D. Francois Venter
Southern African Journal of HIV Medicine | Vol 24, No 1 | a1500 | DOI: https://doi.org/10.4102/sajhivmed.v24i1.1500 | © 2023 Gary Maartens, Phumla Sinxadi, W.D. Francois Venter | This work is licensed under CC Attribution 4.0
Submitted: 31 March 2023 | Published: 15 May 2023

About the author(s)

Gary Maartens, Division of Clinical Pharmacology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
Phumla Sinxadi, Division of Clinical Pharmacology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
W.D. Francois Venter, Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

Abstract

No abstract available.

Keywords

dolutegravir; integrase strand transfer inhibitors; weight gain; obesity; efavirenz

Metrics

Total abstract views: 2662
Total article views: 4475

 

Crossref Citations

1. Simplified antiretroviral treatment regimens: the dolutegravir revolution
MM Makiwane, KC Mothata-Motswaledi, E Osuch
South African General Practitioner  vol: 5  issue: 1  first page: 8  year: 2024  
doi: 10.36303/SAGP.0276